| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $17.8M | — | +24.8% |
| Cost of Revenue | $9.7M | — | +16.8% |
| Gross Profit | $8.1M | — | +35.9% |
| R&D Expense | $2.6M | — | +0.5% |
| SG&A Expense | $5.8M | — | +58.5% |
| Operating Income | -$7.4M | — | -16.8% |
| Pre-tax Income | -$8.9M | — | -22.4% |
| Income Tax | $145K | — | +0.7% |
| Net Income | -$9.1M | — | -22.0% |
| EPS (Basic) | -$0.24 | — | -20.0% |
| EPS (Diluted) | -$0.24 | — | -20.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $15.0M | -26.6% | — |
| Accounts Receivable | $19.7M | -7.7% | — |
| Inventory | $13.3M | +3.9% | — |
| Current Assets | $50.4M | -11.9% | — |
| Total Assets | $72.1M | -8.8% | -11.1% |
| Current Liabilities | $37.5M | +1.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.0M | — | +44.4% |
| Investing Cash Flow | -$754K | — | +42.2% |
| Financing Cash Flow | -$1.4M | — | -9.4% |
| — |
| Long-term Debt | $19.1M | +5.7% | — |
| Total Liabilities | $62.0M | +4.0% | — |
| Stockholders' Equity | $10.1M | -48.0% | -72.9% |